{"schema_version":"alpha-profile-public-v1","slug":"lawrence-a-kenyon","canonical_url":"https://registry.alpha.ac/people/lawrence-a-kenyon","as_of":"2026-09-21T22:57:21.961257+00:00","published_at":"2026-09-02T02:37:22.494367+00:00","last_reviewed_at":"2026-05-16T06:34:00.382+00:00","identity":{"display_name":"Lawrence A. Kenyon","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2015-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=lawrence-a-kenyon","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=lawrence-a-kenyon&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Kenyon has served as a Board member since August 2018, as Chief Financial Officer since September 2015, and as Interim CEO from December 2024 to July 2025. He has extensive biopharmaceutical industry experience, having served as CFO at multiple public companies including Par Pharmaceutical and Alfacell. He is a CPA."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Outlook Therapeutics, Inc.","organizationId":"outlook-therapeutics-inc","title":"Director","period":"2015-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2015-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:46.014958+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:34:00.612182+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T06:34:00.451163+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Lawrence A. Kenyon currently serves as Director at Outlook Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:45.973711+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Executive"],"claim_text":"Lawrence A. Kenyon serves on Executive.","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:45.992109+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Outlook Therapeutics, Inc.","claim_text":"Lawrence A. Kenyon is linked to Outlook Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:46.146288+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"Lawrence A. Kenyon is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:46.127538+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:46.058744+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:34:00.647984+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T06:34:00.451163+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Outlook Therapeutics, Inc.","claim_text":"Lawrence A. Kenyon is associated with Outlook Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:34:00.594158+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T06:34:00.451163+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Executive Vice President, Chief Financial Officer, Treasurer, Corporate Secretary and Director","claim_text":"Lawrence A. Kenyon is listed as Executive Vice President, Chief Financial Officer, Treasurer, Corporate Secretary and Director at Outlook Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:34:00.554861+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T06:34:00.451163+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:46.037977+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:45.869562+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Lawrence A. Kenyon as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:34:00.630198+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T06:34:00.451163+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:lawrence-a-kenyon","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2015-01-01 · current","organization":"Outlook Therapeutics, Inc.","organization_id":"outlook-therapeutics-inc"},"claim_text":"Director at Outlook Therapeutics, Inc. (2015-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/lawrence-a-kenyon#profile","url":"https://registry.alpha.ac/people/lawrence-a-kenyon","dateModified":"2026-05-16T06:34:00.382+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/lawrence-a-kenyon#person","name":"Lawrence A. Kenyon","url":"https://registry.alpha.ac/people/lawrence-a-kenyon","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","tickerSymbol":"NASDAQ: OTLK"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","memberOf":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/outlook-therapeutics-inc","tickerSymbol":"NASDAQ: OTLK"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","name":"OTLK DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/lawrence-a-kenyon"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":4,"sources":4,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T06:34:00.382+00:00","observed_at":"2026-09-21T22:57:21.961257+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"lawrence-a-kenyon","canonical_url":"https://registry.alpha.ac/people/lawrence-a-kenyon"},"publication":{"published_at":"2026-09-02T02:37:22.494367+00:00","last_reviewed_at":"2026-05-16T06:34:00.382+00:00","as_of":"2026-09-21T22:57:21.961257+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/lawrence-a-kenyon","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/lawrence-a-kenyon","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/lawrence-a-kenyon.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}